Evidence-based Psychosocial Interventions in Schizophrenia: a Critical Review

Overview

Journal Curr Opin Psychiatry

Specialty Psychiatry

Date 2024 Feb 27

PMID 38410981

Authors

Stefano Barlati

Gabriele Nibbio

Antonio Vita

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Schizophrenia Spectrum Disorders (SSD) are severe conditions that frequently produce significant impairment in cognitive performance, social skills and psychosocial functioning. As pharmacological treatment alone often provides only limited improvements on these outcomes, several psychosocial interventions are employed in psychiatric rehabilitation practice to improve of real-world outcomes of people living with SSD: the present review aims to provide a critical overview of these treatments, focusing on those that show consistent evidence of effectiveness.

Recent Findings: Several recent systematic reviews and meta-analyses have investigated in detail the acceptability, the effectiveness on several specific outcomes and moderators of response of different psychosocial interventions, and several individual studies have provided novel insight on their implementation and combination in rehabilitation practice.

Summary: Cognitive remediation, metacognitive training, social skills training, psychoeducation, family interventions, cognitive behavioral therapy, physical exercise and lifestyle interventions, supported employment and some other interventions can be fully considered as evidence-based treatments in SSD. Psychosocial interventions could be of particular usefulness in the context of early intervention services. Future research should focus on developing newer interventions, on better understanding the barriers and the facilitators of their implementation in clinical practice, and exploring the opportunities provided by novel technologies.

Citing Articles

Is ketamine efficacious for rapid treatment of acute suicidal ideation in an emergency setting? Lessons learned from a pilot randomized controlled trial.

Barzkar M, Alavi K, Malakouti K, Khajeh-Azad M, Barzkar F, Jalali Nadoushan A BMC Res Notes. 2025; 18(1):65.

PMID: 39940002 PMC: 11823077. DOI: 10.1186/s13104-024-07029-7.

Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies.

Snipes C, Dorner-Ciossek C, Hare B, Besedina O, Campellone T, Petrova M JMIR Ment Health. 2025; 12:e64959.

PMID: 39869902 PMC: 11811661. DOI: 10.2196/64959.

Physical activity interventions to improve cognition in first-episode psychosis: What we know so far.

Perlini C, Rossetti M, Girelli F, Bellani M Eur Psychiatry. 2024; 67(1):e83.

PMID: 39676541 PMC: 11733622. DOI: 10.1192/j.eurpsy.2024.1792.

Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review.

Lisoni J, Nibbio G, Baglioni A, Dini S, Manera B, Maccari A Brain Sci. 2024; 14(11).

PMID: 39595830 PMC: 11591595. DOI: 10.3390/brainsci14111067.

The Relationship between Cognitive Impairment and Violent Behavior in People Living with Schizophrenia Spectrum Disorders: A Critical Review and Treatment Considerations.

Nibbio G, Bertoni L, Calzavara-Pinton I, Necchini N, Paolini S, Baglioni A Medicina (Kaunas). 2024; 60(8).

PMID: 39202542 PMC: 11356552. DOI: 10.3390/medicina60081261.

References

Zheng Y, Xu T, Zhu Y, Li C, Wang J, Livingstone S . Cognitive Behavioral Therapy for Prodromal Stage of Psychosis-Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis. Schizophr Bull. 2021; 48(1):8-19. PMC: 8781350. DOI: 10.1093/schbul/sbab044. View

de Winter L, Couwenbergh C, van Weeghel J, Sanches S, Michon H, Bond G . Who benefits from individual placement and support? A meta-analysis. Epidemiol Psychiatr Sci. 2022; 31:e50. PMC: 9281491. DOI: 10.1017/S2045796022000300. View

Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green M . The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry. 2021; 20(1):4-33. PMC: 7801854. DOI: 10.1002/wps.20809. View

Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabe M . EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry. 2021; 64(1):e21. PMC: 8057437. DOI: 10.1192/j.eurpsy.2021.13. View

Tan B, Shi J, Yang S, Loh H, Ng D, Choo C . The use of virtual reality and augmented reality in psychosocial rehabilitation for adults with neurodevelopmental disorders: A systematic review. Front Psychiatry. 2023; 13:1055204. PMC: 9794993. DOI: 10.3389/fpsyt.2022.1055204. View

Burschinski A, Schneider-Thoma J, Chiocchia V, Schestag K, Wang D, Siafis S . Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials. World Psychiatry. 2023; 22(1):116-128. PMC: 9840505. DOI: 10.1002/wps.21036. View

Granholm E, Twamley E, Mahmood Z, Keller A, Lykins H, Parrish E . Integrated Cognitive-Behavioral Social Skills Training and Compensatory Cognitive Training for Negative Symptoms of Psychosis: Effects in a Pilot Randomized Controlled Trial. Schizophr Bull. 2021; 48(2):359-370. PMC: 8886598. DOI: 10.1093/schbul/sbab126. View

Harvey P, Bosia M, Cavallaro R, Howes O, Kahn R, Leucht S . Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art. Schizophr Res Cogn. 2022; 29:100249. PMC: 8956816. DOI: 10.1016/j.scog.2022.100249. View

McFarlane W, Dixon L, Lukens E, Lucksted A . Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther. 2003; 29(2):223-45. DOI: 10.1111/j.1752-0606.2003.tb01202.x. View

10.

Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016; 50(5):410-72. DOI: 10.1177/0004867416641195. View

11.

Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S . Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry. 2018; 18(1):380. PMC: 6280425. DOI: 10.1186/s12888-018-1964-8. View

12.

Khoury B, Lecomte T, Gaudiano B, Paquin K . Mindfulness interventions for psychosis: a meta-analysis. Schizophr Res. 2013; 150(1):176-84. DOI: 10.1016/j.schres.2013.07.055. View

13.

Allott K, van-der-El K, Bryce S, Parrish E, McGurk S, Hetrick S . Compensatory Interventions for Cognitive Impairments in Psychosis: A Systematic Review and Meta-Analysis. Schizophr Bull. 2020; 46(4):869-883. PMC: 7345816. DOI: 10.1093/schbul/sbz134. View

14.

Firth J, Cotter J, Elliott R, French P, Yung A . A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015; 45(7):1343-61. DOI: 10.1017/S0033291714003110. View

15.

Correll C, Ismail Z, McIntyre R, Rafeyan R, Thase M . Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia. J Clin Psychiatry. 2022; 83(5). DOI: 10.4088/JCP.LU21112AH2. View

16.

Carmona V, Gomez-Benito J, Huedo-Medina T, Rojo J . Employment outcomes for people with schizophrenia spectrum disorder: A meta-analysis of randomized controlled trials. Int J Occup Med Environ Health. 2017; 30(3):345-366. DOI: 10.13075/ijomeh.1896.01074. View

17.

Berendsen S, Berendse S, van der Torren J, Vermeulen J, de Haan L . Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials. EClinicalMedicine. 2024; 67:102392. PMC: 10809079. DOI: 10.1016/j.eclinm.2023.102392. View

18.

Hjorthoj C, Sturup A, McGrath J, Nordentoft M . Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017; 4(4):295-301. DOI: 10.1016/S2215-0366(17)30078-0. View

19.

Taipale H, Tanskanen A, Mehtala J, Vattulainen P, Correll C, Tiihonen J . 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020; 19(1):61-68. PMC: 6953552. DOI: 10.1002/wps.20699. View

20.

Karow A, Wittmann L, Schottle D, Schafer I, Lambert M . The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014; 16(2):185-95. PMC: 4140512. View